Recent progress in the classification of soft tissue tumors: Role of genetics and clinical implications

Current Opinion in Oncology

Volumn 13, Issue 4, 2001, Pages 256-260

  Rubin, Brian P ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CLASSIFICATION; CLINICAL FEATURE; GASTROINTESTINAL TUMOR; GENETICS; HUMAN; MOLECULAR GENETICS; MORPHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SARCOMA; SOFT TISSUE TUMOR;

GASTROINTESTINAL NEOPLASMS; HUMANS; NEOPLASM STAGING; NEOPLASMS, MUSCLE TISSUE; SOFT TISSUE NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034955087     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200107000-00008     Document Type: Review

References (55)

1. Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases
2. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: An historical review with differential diagnostic considerations
3. Inflammatory fibrosarcoma: Update, reappraisal, and perspective on its place in the spectrum of inflammatory myofibroblastic tumors
4. Inflammatory myofibroblastic tumor of bone: Report of two cases with evidence of clonal chromosomal changes
5. Clonal changes in inflammatory pseudotumor of the lung: A case report
6. Omental-mesenteric inflammatory pseudotumor. Cytogenetic demonstration of genetic changes and monoclonality in one tumor
7. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors
8. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors
9. Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms
10. ALK+ lymphoma: Clinico-pathological findings and outcome
11. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma
12. Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: A distinct clinicopathologic entity
13. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia
14. A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation
15. Complex variant translocation t(1;2) with TPM3-ALK fusion due to cryptic ALK gene rearrangement in anaplastic large-cell lymphoma
16. Smooth muscle tumors of the gastrointestinal tract and retroperitoneal tissues
17. Tumeurs myoides intra-murales de l'estomac - Considerations microscopiques a propor de 6 cas
18. Bizarre smooth muscle tumors of the stomach
19. Gastrointestinal stromal tumours: An immunohistochemical study of 165 cases
20. Gastrointestinal stromal tumours: Correlation of immunophenotype with clinicopathological features
21. Cell markers in gastrointestinal stromal tumors
22. Malignant small bowel neoplasm of enteric plexus derivation (plexosarcoma). Light and electron microscopic study confirming the origin of the neoplasm
23. Gastrointestinal autonomic nerve (GAN) tumor. Ultrastructural evidence for a newly recognized entity
24. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
25. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product
26. Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: Establishment of clonality in a human mast cell neoplasm
27. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder
28. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation
29. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3
30. Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids ar the juxtamembrane domain
31. Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
32. Decreased production of mast cells in S1/S1d anemic mice
33. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
34. Gastrointestinal stromal tumors: An update
35. KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors
36. Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas
37. Mutations of c-kit JM domain are found in a minority of human gastrointestinal stromal tumors
38. Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors
39. Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal
40. CD117: A sensitive marker for gastrointestinal stromal tumors that is more specific than CD34
41. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors
42. Mutations in exons 9 and 13 of KIT gene are rare events in gastrointestinal stromal tumors. A study of 200 cases
43. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors
44. Three possible cytogenetic subgroups of leiomyosarcoma
45. Cytogenetic findings in leiomyosarcoma of the small bowel
46. Gastrointestinal stromal tumor, uncommitted type, with monosomies 14 and 22 as the only chromosomal abnormalities
47. Cytogenetic observations in a human gastric leiomyosarcoma
48. Loss of 14q and 22q in gastrointestinal stromal tumors (pacemaker cell tumors)
49. DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors
50. DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance
51. Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor
52. c-kit immunocytochemical staining in the cytologic diagnosis of metastatic gastrointestinal stromal tumor. A report of two cases
53. Analysis of KIT mutation and protein expression in fine needle aspirates of gastrointestinal stromal/smooth muscle tumors
54. Diagnosis of gastrointestinal stromal tumor by fine-needle aspiration biopsy: A cytological and immunocytochemical study
55. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor